The Pharmacokinetics, Metabolism, and Clearance Mechanisms of Abrocitinib, a Selective Janus Kinase Inhibitor, in Humans-Reference-Cited by-同舟云学术

The Pharmacokinetics, Metabolism, and Clearance Mechanisms of Abrocitinib, a Selective Janus Kinase Inhibitor, in Humans

Published:2022-06-14 Issue:8 Volume:50 Page:1106-1118
ISSN:0090-9556
Container-title:Drug Metabolism and Disposition
language:en
Short-container-title:Drug Metab Dispos

Author:

Bauman Jonathan N.,Doran Angela C.,King-Ahmad Amanda,Sharma Raman,Walker Gregory S.,Lin Jian,Lin Tsung H.,Telliez Jean-Baptiste,Tripathy Sakambari,Goosen Theunis C.,Banfield Christopher,Malhotra Bimal K.,Dowty Martin E.^ORCID

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmaceutical Science,Pharmacology

Reference18 articles.

1. Critical Role of Jak2 in the Maintenance and Function of Adult Hematopoietic Stem Cells

2. Abrocitinib versus Placebo or Dupilumab for Atopic Dermatitis;Bieber;N Engl J Med,2021

3. Janus kinase inhibitors for the treatment of rheumatoid arthritis demonstrate similar profiles of in vitro cytokine receptor inhibition;Dowty;Pharmacol Res Perspect,2019

4. Efficacy and Safety of Oral Janus Kinase 1 Inhibitor Abrocitinib for Patients With Atopic Dermatitis: A Phase 2 Randomized Clinical Trial;Gooderham;JAMA Dermatol,2019

5. Determination of mean valproic acid serum level by assay of a single pooled sample

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Endeavours made by trade associations, pharmaceutical companies and regulators in the replacement, reduction and refinement of animal experimentation in safety testing of pharmaceuticals;Regulatory Toxicology and Pharmacology;2024-09

2. Meta‐Analysis of Noncompartmental Pharmacokinetic Parameters to Evaluate the Impact of CYP2C19 and CYP2C9 Genetic Polymorphisms on Abrocitinib Exposure;Clinical Pharmacology in Drug Development;2024-08-30

3. Practical Management of the JAK1 Inhibitor Abrocitinib for Atopic Dermatitis in Clinical Practice: Special Safety Considerations;Dermatology and Therapy;2024-07-02

4. Effects of two commonly used antidepressants amitriptyline and fluoxetine on the pharmacokinetics of abrocitinib in rats;Chemico-Biological Interactions;2024-07

5. Atopic Dermatitis and Abrocitinib: Unraveling the Therapeutic Potential;Current Signal Transduction Therapy;2024-07